Fennec Pharmaceuticals, Inc. Vs. Nebius Group NV Industry Stock Comparison

Sell

24

FRX.TO
Fennec Pharmaceuticals, Inc.

Last Price:

$10.39

Seasonality Move:

17.23%

Sell

42

NBIS
Nebius Group NV

Last Price:

$89.47

Seasonality Move:

-2.57%

Sell

24

Fennec Pharmaceuticals, Inc. (FRX.TO) is a Sell

Is Fennec Pharmaceuticals, Inc. a Buy, Sell or Hold?

The current Fennec Pharmaceuticals, Inc. [FRX.TO] share price is $10.39. The Score for FRX.TO is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
FRX.TO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

42

Nebius Group NV (NBIS) is a Sell

Is Nebius Group NV a Buy, Sell or Hold?

The current Nebius Group NV [NBIS] share price is $89.46. The Score for NBIS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
NBIS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FRX.TO Stock Price Chart

What is Fennec Pharmaceuticals, Inc.'s stock price today?

The Fennec Pharmaceuticals, Inc. share price today is $10.39

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FRX.TO is experiencing slight buying pressure.

NBIS Stock Price Chart

What is Nebius Group NV's stock price today?

The Nebius Group NV share price today is $89.46

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBIS is experiencing buying pressure, which is a positive indicator for future bullish movement.

FRX.TO Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.29	Sell
Relative Strength Index (14 RSI):	33.6	Sell
Chaikin Money Flow:	0	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(10.36 - 11.6)	Sell
Bollinger Bands (100):	(10.96 - 12.56)	Sell

NBIS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-5.05	Sell
Relative Strength Index (14 RSI):	47.32	Sell
Chaikin Money Flow:	13904832	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(83.34 - 98.02)	Sell
Bollinger Bands (100):	(72.32 - 115.66)	Sell

FRX.TO Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	10.51	Sell
20-day SMA:	10.72	Sell
50-day SMA:	11.34	Sell
200-day SMA:	10.84	Sell
8-day EMA:	10.49	Sell
20-day EMA:	10.75	Sell
50-day EMA:	11.21	Sell
200-day EMA:	10.95	Sell

NBIS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	85.08	Buy
20-day SMA:	91.37	Sell
50-day SMA:	102.98	Sell
200-day SMA:	65.21	Buy
8-day EMA:	85.42	Buy
20-day EMA:	90.53	Sell
50-day EMA:	95.55	Sell
200-day EMA:	73.6	Buy

Fennec Pharmaceuticals, Inc. Earnings Growth & FRX.TO Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.06 per share, and an increase next year of $1.25 per share.

Nebius Group NV Earnings Growth & NBIS Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.56 per share.

Fennec Pharmaceuticals, Inc. Technical Analysis

	Dec 8	Dec 9	Dec 10	Dec 11	Dec 12	Dec 15	Dec 16	Dec 17	Dec 18	Dec 19
	Dec
	08	09	10	11	12	15	16	17	18	19
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nebius Group NV Technical Analysis

	Dec 8	Dec 9	Dec 10	Dec 11	Dec 12	Dec 15	Dec 16	Dec 17	Dec 18	Dec 19
	Dec
	08	09	10	11	12	15	16	17	18	19
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):